5-HT1A-like receptor activation inhibits abstinence-induced methamphetamine withdrawal in planarians

Neuroscience Letters

Volumn 484, Issue 2, 2010, Pages 113-117

  Rawls, Scott M ^a,b   Shah, Hardik ^a   Ayoub, George ^a   Raffa, Robert B ^a  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

^b Center for Substance Abuse Research   (United States)

Author keywords

5 HT1A; Dependence; Methamphetamine; Planarian; Serotonin; Withdrawal

Indexed keywords

METHAMPHETAMINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN; SEROTONIN 1A RECEPTOR;

ARTICLE; DRUG DEPENDENCE; DRUG WITHDRAWAL; DUGESIA DOROTOCEPHALA; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TURBELLARIA; WITHDRAWAL SYNDROME;

ANALYSIS OF VARIANCE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; METHAMPHETAMINE; MOVEMENT; PIPERAZINES; PLANARIANS; PYRIDINES; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN RECEPTOR AGONISTS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 77956880236     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.08.027     Document Type: Article

References (39)

1. 1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice. Neuropharmacology 2006, 51:914-922.
2. Bradbury A.J., Costall B., Kelly M.E., Naylor R.J., Smith J.A. Biochemical correlates of motor changes caused by the manipulation of dopamine function in the substantia nigra of the mouse. Neuropharmacology 1985, 24:1155-1161.
3. Carey R.J., Huston J.P., Müller C.P. Pharmacological inhibition of dopamine and serotonin activity blocks spontaneous and cocaine-activated behaviour. Prog. Brain Res. 2008, 172:347-360.
4. Eriksson K.S., Panula P. gamma-Aminobutyric acid in the nervous system of a planarian. J. Comp. Neurol. 1994, 345:528-536.
5. Farrell M.S., Gilmore K., Raffa R.B., Walker E.A. Behavioral characterization of serotonergic activation in the flatworm Planaria. Behav. Pharmacol. 2008, 19:177-182.
6. Francis D.L., Schneider C. Jumping after naloxone precipitated withdrawal of chronic morphine in the rat. Br. J. Pharmacol. 1971, 41:424P-425P.
7. Heinzerling K.G., Swanson A.N., Kim S., Cederblom L., Moe A., Ling W., Shoptaw S. Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend. 2010, 109:20-29.
8. Howell L.L., Kimmel H.L. Monoamine transporters and psychostimulant addiction. Biochem. Pharmacol. 2008, 75:196-217.
9. Kishi T., Tsunoka T., Ikeda M., Kitajima T., Kawashima K., Okochi T., Okumura T., Yamanouchi Y., Kinoshita Y., Ujike H., Inada T., Yamada M., Uchimura N., Sora I., Iyo M., Ozaki N., Iwata N. Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients. Neuropharmacology 2010, 58:452-456.
10. Kusayama T., Watanabe S. Reinforcing effects of methamphetamine in planarians. Neuroreport 2000, 11:2511-2513.
11. Lynch M.A., Leonard B.E. Effect of chronic amphetamine administration on the behaviour of rats in the open field apparatus: reversal of post-withdrawal depression by two antidepressants. J. Pharm. Pharmacol. 1978, 30:798-799.
12. McGregor C., Srisurapanont M., Jittiwutikarn J., Laobhripatr S., Wongtan T., White J.M. The nature, time course and severity of methamphetamine withdrawal. Addiction 2005, 100:1320-1329.
13. Moser P.C., Moran P.M., Frank R.A., Kehne J.H. Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist. Behav. Brain Res. 1996, 73:163-167.
14. Müller C.P., Carey R.J., Huston J.P., De Souza Silva M.A. Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors. Prog. Neurobiol. 2007, 81:133-178.
15. Pagán O.R., Rowlands A.L., Fattore A.L., Coudron T., Urban K.R., Bidja A.H., Eterović V.A. A cembranoid from tobacco prevents the expression of nicotine-induced withdrawal behavior in planarian worms. Eur. J. Pharmacol. 2009, 615:118-124.
16. Paine T.A., Jackman S.L., Olmstead M.C. Cocaine-induced anxiety: alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine. Behav. Pharmacol. 2002, 13:511-523.
17. Palladini G., Ruggeri S., Stocchi F., De Pandis M.F., Venturini G., Margotta V. A pharmacological study of cocaine activity in planaria. Comp. Biochem. Physiol. C: Pharmacol. Toxicol. Endocrinol. 1996, 115:41-45.
18. Parsons L.H., Justice J.B. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. J. Neurochem. 1993, 61:1611-1619.
19. Parsons L.H., Koob G.F., Weiss F. Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J. Pharmacol. Exp. Ther. 1995, 274:1182-1191.
20. Paulson P.E., Camp D.M., Robinson T.E. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology 1991, 103:480-492.
21. Phelix C.F., Broderick P.A. Light microscopic immunocytochemical evidence of converging serotonin and dopamine terminals in ventrolateral nucleus accumbens. Brain Res. Bull. 1995, 37:37-40.
22. Prisco S., Pagannone S., Esposito E. Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo. J. Pharmacol. Exp. Ther. 1994, 271:83-90.
23. Przegaliñski E., Filip M. Stimulation of serotonin (5-HT)1A receptors attenuates the locomotor, but not the discriminative, effects of amphetamine and cocaine in rats. Behav. Pharmacol. 1997, 8:699-706.
24. Przegaliński E., Siwanowicz J., Baran L., Filip M. Activation of serotonin (5-HT)1A receptors inhibits amphetamine sensitization in mice. Life Sci. 2000, 66:1011-1019.
25. Raffa R.B., Stagliano G.W., Umeda S. kappa-Opioid withdrawal in Planaria. Neurosci. Lett. 2003, 349:139-142.
26. Raffa R.B., Desai P. Description and quantification of cocaine withdrawal signs in Planaria. Brain Res. 2005, 1032:200-202.
27. Raffa R.B., Martley A.F. Amphetamine-induced increase in planarian locomotor activity and block by UV light. Brain Res. 2005, 1031:138-140.
28. Rawls S.M., Gomez T., Stagliano G.W., Raffa R.B. Measurement of glutamate and aspartate in Planaria. J. Pharmacol. Toxicol. Methods 2006, 53:291-295.
29. Rawls S.M., Gomez T., Raffa R.B. An NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 55212-2). Pharmacol. Biochem. Behav. 2007, 86:499-504.
30. Rawls S.M., Gerber K., Ding Z., Roth C., Raffa R.B. Agmatine: identification and inhibition of methamphetamine, kappa opioid, and cannabinoid withdrawal in planarians. Synapse 2008, 62:927-934.
31. Rawls S.M., Baron S., Ding Z., Roth C., Zaveri N., Raffa R.B. Nociceptin attenuates methamphetamine abstinence-induced withdrawal-like behavior in planarians. Neuropeptides 2008, 42:229-237.
32. Rothman R.B., Blough B.E., Baumann M.H. Dual dopamine-5-HT releasers: potential treatment agents for cocaine addiction. Trends Pharmacol. Sci. 2006, 27:612-618.
33. Sacavage S., Patel H., Zielinski M., Acker J., Phillips A.G., Raffa R.B., Rawls S.M. Withdrawal-like behavior in planarians is dependent on drug exposure duration. Neurosci. Lett. 2008, 439:84-88.
34. Saitoh O., Yuruzume E., Watanabe K., Nakata H. Molecular identification of a G protein-coupled receptor family which is expressed in planarians. Gene 1997, 195:55-61.
35. Segal D.S., Kuczenski R. Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization. J. Pharmacol. Exp. Ther. 1997, 282:561-573.
36. Shoptaw S., Rawson R.A., McCann M.J., Obert J.L. The Matrix model of outpatient stimulant abuse treatment: evidence of efficacy. J. Addict. Dis. 1994, 13:129-141.
37. Shoptaw S.J., Kao U., Heinzerling K., Ling W. Treatment for amphetamine withdrawal. Cochrane Database Syst. Rev. 2009, 15:CD003021.
38. Takamatsu Y., Yamamoto H., Ogai Y., Hagino Y., Markou A., Ikeda K. Fluoxetine as a potential pharmacotherapy for methamphetamine dependence: studies in mice. Ann. N. Y. Acad. Sci. 2006, 1074:295-302.
39. Umeda S., Stagliano G.W., Borenstein M.R., Raffa R.B. A reverse-phase HPLC and fluorescence detection method for measurement of 5-hydroxytryptamine (serotonin) in Planaria. J. Pharmacol. Toxicol. Methods 2005, 51:73-76.